{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:31:19Z","timestamp":1772915479595,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1984,4,1]],"date-time":"1984-04-01T00:00:00Z","timestamp":449625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1984,4]]},"DOI":"10.1007\/bf03348396","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T12:09:46Z","timestamp":1396613386000},"page":"93-96","source":"Crossref","is-referenced-by-count":16,"title":["Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion"],"prefix":"10.1007","volume":"7","author":[{"given":"P.","family":"Loli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Berselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Frascatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"BF03348396_CR1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM197510302931802","volume":"293","author":"DT Krieger","year":"1975","unstructured":"Krieger D.T., Amorosa L., Linick F. Cyproheptadine-induced remission of Cushing\u2019s disease. N. Engl. J. Med. 293: 893, 1975.","journal-title":"N. Engl. J. Med."},{"key":"BF03348396_CR2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-43-5-1179","volume":"43","author":"DT Krieger","year":"1976","unstructured":"Krieger D.T., Luria M. Effectiveness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson\u2019s syndrome. J. Clin. Endocrinol. Metab. 43: 1179, 1976.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348396_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.1977.tb01314.x","volume":"7","author":"SWJ Lamberts","year":"1977","unstructured":"Lamberts S.W.J., Timmermans H.A.T., De Jong F.H., Birkenhager J.C. The role of dopaminergic depletion in the pathogenesis of Cushing\u2019s disease and the possible consequences for medical therapy. Clin. Endocrinol. (Oxf.) 7: 185, 1977.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03348396_CR4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1210\/jcem-54-4-780","volume":"54","author":"G Tolis","year":"1982","unstructured":"Tolis G., Jukier L., Wiesen M., Krieger D.T. Effect of naloxone on pituitary hypersecretory syndromes. J. Clin. Endocrinol. Metab. 54: 780, 1982.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348396_CR5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(81)92349-7","volume":"7","author":"MT Jones","year":"1981","unstructured":"Jones M.T., Gillham B., Beckford U. Effect of treatment with sodium valproate and diazepam on plasma corticotropin in Nelson\u2019s syndrome. Lancet 7: 1179, 1981.","journal-title":"Lancet"},{"key":"BF03348396_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1981.tb00649.x","volume":"15","author":"AN Elias","year":"1981","unstructured":"Elias A.N., Gwinup G., Valenta L.J. Effects of valproic acid, naloxone and hydrocortisone in Nelson\u2019s syndrome and Cushing\u2019s disease. Clin. Endocrinol. (Oxf.) 15: 151, 1981.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03348396_CR7","first-page":"113","volume-title":"Proc. of the International Workshop, Pituitary hyperfunction, Physiopathology and clinical aspects. Milan","author":"A Dornhorst","year":"1982","unstructured":"Dornhorst A., Abraham R.R., Jenkins J.S., Beckford U., Gillham B., Jones M.T. The biochemical and clinical evaluation of sodium valproate in Nelson\u2019s syndrome. Proc. of the International Workshop, Pituitary hyperfunction, Physiopathology and clinical aspects. Milan, 1982, p. 113 (Abstract)."},{"key":"BF03348396_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(82)90422-6","volume":"7","author":"B Allolio","year":"1982","unstructured":"Allolio B., Winkelmann W., Kaulen D., Hipp F.X., Mies R. Valproate in Cushing\u2019s syndrome. Lancet 7: 171, 1982.","journal-title":"Lancet"},{"key":"BF03348396_CR9","first-page":"120","volume":"246","author":"W Winkelmann","year":"1982","unstructured":"Winkelmann W., Allolio B., Hipp F.X., Kaulen D. Missing effect of valproate on plasma ACTH in patients with Cushing\u2019s disease or primary adrenal insufficiency. Acta Endocrinol. (Kbh.) (Suppl.) 246: 120, 1982.","journal-title":"Acta Endocrinol. (Kbh.)"},{"key":"BF03348396_CR10","first-page":"213","volume-title":"Neuroactive drugs in endocrinology","author":"L Grandison","year":"1980","unstructured":"Grandison L., Guidotti A. Role of the anterior pituitary GABA receptor in the control of prolactin release. In: Muller E.E. (Ed.), Neuroactive drugs in endocrinology. Elsevier, North Holland, 1980, p. 213."},{"key":"BF03348396_CR11","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1210\/jcem-47-6-1348","volume":"47","author":"CA Tamminga","year":"1978","unstructured":"Tamminga C.A., Neophytides A., Chase T.N., Frohman L.A. Stimulation of prolactin and growth hormone secretion by muscimol, a y aminobutyric acid agonist. J. Clin. Endocrinol. Metab. 47: 1348, 1978.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348396_CR12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1471-4159.1969.tb08975.x","volume":"76","author":"Y Godin","year":"1969","unstructured":"Godin Y., Heiner L., Mark J., Mandel P. Effects of di-n-propylacetate, an anticonvulsive compound, on GABA metabolism. J. Neurochem. 76:869, 1969.","journal-title":"J. Neurochem."},{"key":"BF03348396_CR13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1528-1157.1975.tb04747.x","volume":"76","author":"MCB Sawaya","year":"1975","unstructured":"Sawaya M.C.B., Horton R.W., Meldrum B.S. Effect of anticonvulsant drugs on the cerebral enzymes metaboiizing GABA. Epilepsia 76:649, 1975.","journal-title":"Epilepsia"},{"key":"BF03348396_CR14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1471-4159.1978.tb10771.x","volume":"30","author":"TL Perry","year":"1978","unstructured":"Perry T.L., Hansen S. Biochemical effects in man and rat of three drugs which can increase brain GABA content. J. Neurochem. 30:679, 1978.","journal-title":"J. Neurochem."},{"key":"BF03348396_CR15","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/0024-3205(81)90504-X","volume":"28","author":"W L\u00f6scher","year":"1981","unstructured":"L\u00f6scher W., Schmidt D. Plasma GABA levels in neurological patients under treatment with valproic acid. Life Sci. 28: 2383, 1981.","journal-title":"Life Sci."},{"key":"BF03348396_CR16","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/0024-3205(81)90629-9","volume":"29","author":"EJ Hammond","year":"1981","unstructured":"Hammond E.J., Wilder B.J., Bruni J. Central actions of valproic acid in man and in experimental models of epilepsy. Life Sci. 29:2561, 1981.","journal-title":"Life Sci."},{"key":"BF03348396_CR17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0006-2952(81)80001-9","volume":"30","author":"MG Palfreyman","year":"1981","unstructured":"Palfreyman M.G., Schechter P.J., Buckett W.R., Tell G.P., Koch-Weser J. The pharmacology of GABA-transaminase inhibitors. Biochem. Pharmacol. 30: 817, 1981.","journal-title":"Biochem. Pharmacol."},{"key":"BF03348396_CR18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0006-2952(81)90033-2","volume":"30","author":"SJ Enna","year":"1981","unstructured":"Enna S.J. GABA receptor pharmacology-functional considerations. Biochem. Pharmacol. 30: 907, 1981.","journal-title":"Biochem. Pharmacol."},{"key":"BF03348396_CR19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000122564","volume":"16","author":"GB Makara","year":"1974","unstructured":"Makara G.B., Stark E. Effect of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release. Neuroendocrinology 16: 178, 1974.","journal-title":"Neuroendocrinology"},{"key":"BF03348396_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.0690001","volume":"69","author":"MT Jones","year":"1976","unstructured":"Jones M.T., Hillhouse E.W., Burden J. Effect of various putative neurotransmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro 3- a model of the neurotransmitters involved. J. Endocrinol. 69: 1, 1976.","journal-title":"J. Endocrinol."},{"key":"BF03348396_CR21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1677\/joe.0.0770137","volume":"77","author":"Z Acs","year":"1978","unstructured":"Acs Z., Stark E. Possible role of gamma-aminobutyric acid synthesis in the mechanism of dexamethasone feedback action. J. Endocrinol. 77: 137, 1978.","journal-title":"J. Endocrinol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03348396\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:42:19Z","timestamp":1558521739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03348396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1984,4]]}},"alternative-id":["BF03348396"],"URL":"https:\/\/doi.org\/10.1007\/bf03348396","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,4]]}}}